Sanofi-Aventis U.S. LLC recalls Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewa
Recalled May 24, 2023 · FDA recall D-0575-2023 · Sanofi-Aventis U.S
Hazard
Lack of Assurance of Sterility: Malformed crimped collar seal · FDA Class II
Units
51,325 vials
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility: Malformed crimped collar seal
Product
Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05
Manufacturer(s)
Sanofi-Aventis U.S. LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →